168 results on '"Singh, Zeba N."'
Search Results
2. Trouble afoot: Mycosis fungoides bullosa at an unusual site
3. When Flow Is Turbulent: CD19 Intensity Is a Pitfall in Acute Leukemia Classification
4. Macrophage activation syndrome after granulocyte colony‐stimulating factor in a patient with systemic lupus erythematosus
5. A 23-Year-Old Man With Acquired Immune Deficiency Syndrome and Lymphadenopathy
6. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
7. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms
8. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate
9. High-risk acute promyelocytic leukemia with unusual T/myeloid immunophenotype successfully treated with ATRA and arsenic trioxide-based regimen
10. B-acute lymphoblastic leukemia with eosinophilic inclusions
11. Subcutaneous and Disseminated Infection in a Renal Transplant Patient
12. Myelodysplasia and Myeloid Proliferations
13. Childhood Lymphoma
14. Molecular Techniques Used in the Evaluation of Pediatric Acute Leukemia
15. Acute Leukemia
16. The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations
17. Therapy-related B-lymphoblastic leukemia after multiple myeloma
18. A 23-Year-Old Man With Acquired Immune Deficiency Syndrome and Lymphadenopathy
19. Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature
20. Acute alopecia with underlying pruritic erythema
21. Primary myelofibrosis in a patient with sickle cell disease
22. Macrophage activation syndrome after granulocyte colony‐stimulating factor in a patient with systemic lupus erythematosus.
23. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo
24. Cytopenia, Dysplasia, and Monocytosis: A Precursor To Chronic Myelomonocytic Leukemia or a Distinct Subgroup? Case Reports and Review of Literature
25. Biologic Implications of t(11;14) in Multiple Myeloma Explained With a Case of Refractory Disease Sensitive to Venetoclax
26. Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study
27. Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia
28. Renal dysplasia: An autopsy study of associated congential malformations
29. Cost Effectiveness of AFB Staining in Tissue Specimens
30. Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma
31. Abstract 542: Anti-CD19 therapy for precursor B-acute lymphoblastic leukemia: Response and resistance mechanisms
32. Babesiosis Masquerading as Evans Syndrome
33. The Performance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis in Critically Ill Patients
34. Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib
35. Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab
36. Subcutaneous and Disseminated Infection in a Renal Transplant Patient.
37. The Performance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
38. Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
39. Acute Onset Unilateral Proptosis
40. Cryptic ETV6–PDGFRB fusion in a highly complex rearrangement of chromosomes 1, 5, and 12 due to a chromothripsis-like event in a myelodysplastic syndrome/myeloproliferative neoplasm
41. Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer
42. Cryptic ETV6–PDGFRB fusion in a highly complex rearrangement of chromosomes 1, 5, and 12 due to a chromothripsis-like event in a myelodysplastic syndrome/myeloproliferative neoplasm.
43. A Subset of Classical Hodgkin Lymphoma Cases Demonstrate CD19 Expression on Hodgkin Reed-Sternberg Cells By Immunohistochemistry
44. Primary and Secondary Plasma Cell Leukemia Risk Stratification By Circulating Plasma Cells
45. Inefficient megakaryopoiesis in mouse hematopoietic stem–progenitor cells lacking T-bet
46. Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols
47. Non-Producing Multiple Myeloma (MM) Is a Distinct Subset Of Non-Secretory MM Characterized By High Cyclin D1 Expression and Decreased Progression Free Survival
48. Primary myelofibrosis in a patient with sickle cell disease.
49. Secondary Myelodysplasia-Associated Metaphase Cytogenetic Abnormalities in Newly Diagnosed Multiple Myeloma Treated On Total Therapies 2 & 3– Influence of Cumulative Dosing of Maintenance Drugs
50. Fulminant Onset of Acute Leukemia (FOAL) After Total Therapies (TT) for Multiple Myeloma (MM): Absence of MDS Pathological Criteria within 3 Months of Prior MM Follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.